Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank0
3Y CAGR-40.4%
5Y CAGR-36.6%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-40.4%/yr
vs +10.3%/yr prior
5Y CAGR
-36.6%/yr
Recent deceleration
Acceleration
-50.6pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20251.99-62.4%
20245.30-50.9%
202310.79+14.6%
20229.42-38.7%
202115.37-20.8%
202019.41+364.1%
20194.18-34.4%
20186.37-